KLRA today
$12.97+$0.80 (+6.57%)close Nov 6, 2026Trend
DailyDowntrend (confirmed)
4 hourSymmetric Triangle
1 hourStrong Bearish
15 minSymmetric Triangle
5 minStrong Bullish
Daily trend turns up above $11.24
Key levels
Resistance$15.15
Resistance$13.83
Support$11.24
Support$9.76
Latest news & SEC filings
EarningsKailera Therapeutics posts smaller quarterly loss than expected
EarningsKailera Therapeutics Posts Q3 2026 Financials
All KLRA news →Nasdaq · Healthcare
Kailera Therapeutics, Inc. (KLRA)
What Is the Price Target for KLRA?
SEPT Low Target
$30.60
SEPT Mid Target
$36.00
SEPT High Target
$41.40
Analyst Consensus
$36.00
Is KLRA a Buy or Sell Right Now?
Thesis
- •Smart money flows are positive — institutional and insider activity supports thesis.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for KLRA.
Start Free Trial →Is KLRA Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$36.00
5
Moat Score
NONE
0/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with KLRA?
Insider Signal
BUYING
4 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Renaud Ronald C JR | director officer | Buy | 38,094 | $200K | Jun 9, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →KLRA Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
N/A
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for KLRA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for KLRA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:01:10 | $12.97 | 2,000 | $$26K | BUY |
| 21:01:08 | $12.97 | 2,808 | $$36K | BUY |
| 21:00:10 | $12.97 | 3,365 | $$44K | BUY |
| 21:00:00 | $12.97 | 1,300 | $$17K | BUY |
| 20:09:49 | $13.21 | 1,100 | $$15K | MIDPOINT |
5 dark pool trades shown · $$137K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Kailera Therapeutics, Inc. (KLRA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings intelligence, and a complete investment thesis with entry and exit recommendations.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →KLRA — frequently asked questions
What is KLRA stock price today?
Kailera Therapeutics, Inc. (KLRA) is at $12.97, up 6.57% (+$0.80) at the Nov 6, 2026 close.
Why is KLRA stock moving today?
Latest KLRA news — Nov 4, 2026: Kailera Therapeutics posts smaller quarterly loss than expected · Nov 4, 2026: Kailera Therapeutics Posts Q3 2026 Financials
What is the KLRA price target?
The average analyst price target for KLRA is $36.00, ranging from $30 to $48, based on 3 analysts. Latest: JP Morgan initiates on May 12, 2026.
What do analysts rate KLRA?
Analyst ratings for KLRA: 0 Buy, 4 Hold, 0 Sell — consensus Hold.
Did KLRA beat earnings?
KLRA last reported on Aug 12, 2026: EPS -$1.09 vs -$0.90 expected — a miss of 21.6%.
What are KLRA support and resistance levels?
Support: $11.24, $9.76. Resistance: $13.83, $15.15, $17.06.
What are insiders doing with KLRA?
Insider activity: BUYING, 4 buys and 0 sells in the last 90 days.
What is the latest news on KLRA?
Nov 4, 2026: Kailera Therapeutics posts smaller quarterly loss than expected · Nov 4, 2026: Kailera Therapeutics Posts Q3 2026 Financials